AB-x Synthetic Cannabinoids Cannabinoid Research

AB-x Synthetic Cannabinoids Research Dashboard

2

Primary Studies

0

Related Studies

2

Total Studies

Clinical Studies

0

Double-blind human trials

0

Clinical human trials

Pre-Clinical Studies

0

Meta-analyses/Reviews

1

Animal studies

1

Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 2 studies associated with AB-x Synthetic Cannabinoids.

Here is a small sampling of AB-x Synthetic Cannabinoids studies by title:


Components of the AB-x Synthetic Cannabinoids Research Dashboard

  • Top medical conditions associated with AB-x Synthetic Cannabinoids
  • Proven effects in clinical trials for AB-x Synthetic Cannabinoids
  • Receptors associated with AB-x Synthetic Cannabinoids
  • Individual study details for AB-x Synthetic Cannabinoids

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - AB-x Synthetic Cannabinoids

Description of AB-x Synthetic Cannabinoids

The AB class of synthetic cannabinoids is one that commonly use an acronym after their chemical name such as AB-CHFUPYCA, which is based on its systematic name N-(1-Amino-3-methyl-1-oxoButan-2-yl)-1-(CycloHexylmethyl)-3-(4-FlUorophenyl)-1H-PYrazole-5-CarboxAmide. AB-FUBINICA has been associated with a number of life-threatening over-dose effects in people using street drugs sold as synthetic cannabis.

Other Names:

AB Family Synthetic Cannabinoids

AB-x Synthetic Cannabinoids Properties and Effects

Psychoactive, hypothermia and bradycardia at doses of 0.3-3 mg/kg.

AB-x Synthetic Cannabinoids Receptor Binding

Strong affinity for CB1 with a Ki of 0.9nM. Strong affinity for CB2 with a Ki of ~23nM

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.